Cargando…

SMARCA4-deficient thoracic tumor detected by [(18)F]FDG PET/CT

BACKGROUND: SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a distinct entity of undifferentiated thoracic malignancies newly introduced in 2015. Due to its unique clinical characteristic with aggressive thoracic tumor mostly observed in heavy smoker man with emphysema, with poor prognosis, many p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okazaki, Tsubasa, Yokoyama, Kota, Tsuchiya, Jyunichi, Honda, Takayuki, Ishikawa, Yuya, Kirimura, Susumu, Miyazaki, Yasunari, Tateishi, Ukihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218169/ https://www.ncbi.nlm.nih.gov/pubmed/34181162 http://dx.doi.org/10.1186/s41824-021-00102-5

Ejemplares similares

Comparison of [(18)F]FDG PET/CT and MRI for Treatment Response Assessment in Multiple Myeloma: A Meta-Analysis
por: Yokoyama, Kota, et al.
Publicado: (2021)

Additional Value of [(18)F]FDG PET or PET/CT for Response Assessment of Patients with Gastrointestinal Stromal Tumor Undergoing Molecular Targeted Therapy: A Meta-Analysis
por: Yokoyama, Kota, et al.
Publicado: (2021)

Enhancement of (18)F-Fluorodeoxyglucose PET Image Quality by Deep-Learning-Based Image Reconstruction Using Advanced Intelligent Clear-IQ Engine in Semiconductor-Based PET/CT Scanners
por: Yamagiwa, Ken, et al.
Publicado: (2022)

A Rare Case of Radiation-Induced Liver Disease in Treated Abdominal Lymphoma Showing High [(18)F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose
por: Usami, Aya, et al.
Publicado: (2022)

Image quality and quantification accuracy dependence on patient body mass in (89)Zr PET/CT imaging
por: Tateishi, Ukihide, et al.
Publicado: (2021)

Takayasu arteritis: clinical importance of extra-vessel uptake on FDG PET/CT
por: Tsuchiya, Junichi, et al.
Publicado: (2019)

(18)F-FDG PET/CT imaging of atypical subacute thyroiditis in thyrotoxicosis: A case report
por: Yoshida, Katsuya, et al.
Publicado: (2017)

Seventy FDG-PET/CT Cases in Which Nuclear Medicine Physicians Suspected Lymphoma: How Reliable Are We?
por: Toriihara, Akira, et al.
Publicado: (2017)

Dual-time-point FDG-PET/CT Imaging of Temporal Bone Chondroblastoma: A Report of Two Cases
por: Toriihara, Akira, et al.
Publicado: (2015)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Deep learning-based image quality improvement of (18)F-fluorodeoxyglucose positron emission tomography: a retrospective observational study
por: Tsuchiya, Junichi, et al.
Publicado: (2021)

Correlation between choline kinase alpha expression and (11)C-choline accumulation in breast cancer using positron emission tomography/computed tomography: a retrospective study
por: Ozawa, Akane, et al.
Publicado: (2023)

Halo artifacts of indwelling urinary catheter by inaccurate scatter correction in (18)F-FDG PET/CT imaging: incidence, mechanism, and solutions
por: Magota, Keiichi, et al.
Publicado: (2020)

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

A case of 18 F-FDG- PET positive chronic expanding hematoma in the retroperitoneum
por: Katami, Akinobu, et al.
Publicado: (2023)

Response to ‘Is the case really a SMARCA4‐deficient thoracic sarcoma?’
por: Takada, Kohichi, et al.
Publicado: (2020)

SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)

Dynamic and Static (18)F-FDG PET/CT Imaging in SMARCA4-Deficient Non-Small Cell Lung Cancer and Response to Therapy: A Case Report
por: Wumener, Xieraili, et al.
Publicado: (2023)

Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers
por: Shirai, Katsuyuki, et al.
Publicado: (2012)

Improved image resolution on thoracic carcinomas by quantitative (18)F-FDG coincidence SPECT/CT in comparison to (18)F-FDG PET/CT
por: Zheng, Yuming, et al.
Publicado: (2020)

Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
por: Ueno, Daiki, et al.
Publicado: (2012)

Branch-like enhancement on contrast enhanced MRI is a specific finding of cerebellar lymphoma compared with other pathologies
por: Yokoyama, Kota, et al.
Publicado: (2022)

Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis
por: Nukui, Yoshihisa, et al.
Publicado: (2019)

Impact of maximum Standardized Uptake Value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report
por: Namura, Kazuhiro, et al.
Publicado: (2010)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy
por: Nakaigawa, Noboru, et al.
Publicado: (2017)

Late relapsing testicular cancer detected with 18F-FDG PET preceded by long-term alpha-fetoprotein elevation
por: Sakurai, Hiromichi, et al.
Publicado: (2023)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases
por: Chang, Jung Min, et al.
Publicado: (2006)

Active Herpes Zoster Mimicking Worsening of Axillary Lymph Node Metastases of Breast Cancer after Chemotherapy on 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography
por: Fujioka, Tomoyuki, et al.
Publicado: (2021)

(18)F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery
por: Yoon, Hee-Young, et al.
Publicado: (2021)

SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma
por: Khanchel, Fatma, et al.
Publicado: (2021)

Thoracic SMARCA4-deficient undifferentiated tumor—a case of an aggressive neoplasm—case report
por: Roden, Anja C.
Publicado: (2021)

(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy
por: Uchida, Kenzo, et al.
Publicado: (2013)

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
por: Kakizoe, Manabu, et al.
Publicado: (2014)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
por: Nakaigawa, Noboru, et al.
Publicado: (2016)

(18)F-FDG PET/CT Imaging of Primary Hepatic Neuroendocrine Tumor
por: Mitamura, Katsuya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dvqf7agv66pmfh7i7h790ggk3j